Related references
Note: Only part of the references are listed.The role of the calcitonin receptor in protecting against induced hypercalcemia is mediated via its actions in osteoclasts to inhibit bone resorption
Andrew G. Turner et al.
BONE (2011)
Neuroprotective properties of GLP-1: theoretical and practical applications
Jens Juul Holst et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Neuronal Receptor Activity-Modifying Protein 1 Promotes Energy Expenditure in Mice
Zhongming Zhang et al.
DIABETES (2011)
An overview of once-weekly glucagon-like peptide-1 receptor agonists-available efficacy and safety data and perspectives for the future
S. Madsbad et al.
DIABETES OBESITY & METABOLISM (2011)
Endogenous GLP-1 Regulates Postprandial Glycemia in Humans: Relative Contributions of Insulin, Glucagon, and Gastric Emptying
Mathias Nicolaus et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Novel GLP-1 Mimetics Developed To Treat Type 2 Diabetes Promote Progenitor Cell Proliferation in the Brain
A. Hamilton et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
Effects of Exendin-4 Alone and With Peptide YY3-36 on Food Intake and Body Weight in Diet-Induced Obese Rats
Roger D. Reidelberger et al.
OBESITY (2011)
GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice
Eva Tomas et al.
REGULATORY PEPTIDES (2011)
Involvement of endogenous glucagon-like peptide-1 in regulation of gastric motility and pancreatic endocrine secretion
Anne-Barbara Witte et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjects
Robert E. Steinert et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
Noradrenergic neurons of the area postrema mediate amylin's hypophagic action
Catarina S. Potes et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2010)
Dose combinations of exendin-4 and salmon calcitonin produce additive and synergistic reductions in food intake in nonhuman primates
Nicholas T. Bello et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2010)
Lesions of area postrema and subfornical organ alter exendin-4-induced brain activation without preventing the hypophagic effect of the GLP-1 receptor agonist
Elena-Dana Baraboi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2010)
Synthesis and Characterization of Ester-Based Prodrugs of Glucagon-Like Peptide 1
Arnab De et al.
BIOPOLYMERS (2010)
Weighing in on synergy: Preclinical research on neurohormonal anti-obesity combinations
Jonathan D. Roth et al.
BRAIN RESEARCH (2010)
Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection
Alexander Harkavyi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Pharmacokinetics and Pharmacodynamics of Inhaled GLP-1 (MKC253): Proof-of-Concept Studies in Healthy Normal Volunteers and in Patients With Type 2 Diabetes
M. T. Marino et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Once-Weekly GLP-1 Agonists: How Do They Differ from Exenatide and Liraglutide?
Mikkel Christensen et al.
CURRENT DIABETES REPORTS (2010)
Gut-brain cross-talk in appetite regulation
Jaimini Cegla et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2010)
Novel Small Molecule Glucagon-Like Peptide-1 Receptor Agonist Stimulates Insulin Secretion in Rodents and From Human Islets
Kyle W. Sloop et al.
DIABETES (2010)
Enhanced Amylin-Mediated Body Weight Loss in Estradiol-Deficient Diet-Induced Obese Rats
James L. Trevaskis et al.
ENDOCRINOLOGY (2010)
Mechanisms of Amylin/Leptin Synergy in Rodent Models
Victoria F. Turek et al.
ENDOCRINOLOGY (2010)
Glucagon-Like Peptide-1 Receptor Agonists Activate Rodent Thyroid C-Cells Causing Calcitonin Release and C-Cell Proliferation
Lotte Bjerre Knudsen et al.
ENDOCRINOLOGY (2010)
Glucagon-Like Peptide-1 Receptor Knockout Mice Are Protected from High-Fat Diet-Induced Insulin Resistance
Julio E. Ayala et al.
ENDOCRINOLOGY (2010)
Insulin-releasing and metabolic effects of small molecule GLP-1 receptor agonist 6,7-dichloro-2-methylsulfonyl-3-N-tert-butylaminoquinoxaline
Nigel Irwin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight
C. M. Mack et al.
INTERNATIONAL JOURNAL OF OBESITY (2010)
GLP-1 Receptor Stimulation Reduces Amyloid-beta Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease
Yazhou Li et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Spatial Approximations between Residues 6 and 12 in the Amino-terminal Region of Glucagon-like Peptide 1 and Its Receptor A REGION CRITICAL FOR BIOLOGICAL ACTIVITY
Quan Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Do the Actions of Glucagon-Like Peptide-1 on Gastric Emptying, Appetite, and Food Intake Involve Release of Amylin in Humans?
Meena Asmar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Endogenous Glucagon-Like Peptide-1 Slows Gastric Emptying in Healthy Subjects, Attenuating Postprandial Glycemia
Adam M. Deane et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Development of Potent Glucagon-like Peptide-1 Agonists with High Enzyme Stability via Introduction of Multiple Lactam Bridges
Eunice N. Murage et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Allosteric Ligands of the Glucagon-Like Peptide 1 Receptor (GLP-1R) Differentially Modulate Endogenous and Exogenous Peptide Responses in a Pathway-Selective Manner: Implications for Drug Screening
Cassandra Koole et al.
MOLECULAR PHARMACOLOGY (2010)
Brainstem mechanisms of amylin-induced anorexia
Catarina Soares Potes et al.
PHYSIOLOGY & BEHAVIOR (2010)
Multi-hormonal weight loss combinations in diet-induced obese rats: Therapeutic potential of cholecystokinin?
James L. Trevaskis et al.
PHYSIOLOGY & BEHAVIOR (2010)
Paracrinology of islets and the paracrinopathy of diabetes
Roger H. Unger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Insights into amylin-leptin synergy
James L. Trevaskis et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
Diet-derived nutrients mediate the inhibition of hypothalamic NPY neurons in the arcuate nucleus of mice during refeeding
Csilla Becskei et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2009)
Implications of Amylin Receptor Agonism
Jonathan D. Roth et al.
ARCHIVES OF NEUROLOGY (2009)
Obesity treatment: novel peripheral targets
Benjamin C. T. Field et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Differences in the Central Anorectic Effects of Glucagon-Like Peptide-1 and Exendin-4 in Rats
Jason G. Barrera et al.
DIABETES (2009)
Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
Alessandro Pocai et al.
DIABETES (2009)
Modulating receptor function through RAMPs: can they represent drug targets in themselves?
Patrick M. Sexton et al.
DRUG DISCOVERY TODAY (2009)
Minireview: Finding the Sweet Spot: Peripheral Versus Central Glucagon-Like Peptide 1 Action in Feeding and Glucose Homeostasis
Diana L. Williams
ENDOCRINOLOGY (2009)
Intrameal Hepatic Portal and Intraperitoneal Infusions of Glucagon-Like Peptide-1 Reduce Spontaneous Meal Size in the Rat via Different Mechanisms
Elisabeth B. Ruettimann et al.
ENDOCRINOLOGY (2009)
Evidence that Intestinal Glucagon-Like Peptide-1 Plays a Physiological Role in Satiety
Diana L. Williams et al.
ENDOCRINOLOGY (2009)
Exenatide once weekly for the treatment of type 2 diabetes
James Malone et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Eleven Amino Acid Glucagon-like Peptide-1 Receptor Agonists with Antidiabetic Activity
Claudio Mapelli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Hindbrain Cocaine- And Amphetamine-Regulated Transcript Induces Hypothermia Mediated by GLP-1 Receptors
Karolina P. Skibicka et al.
JOURNAL OF NEUROSCIENCE (2009)
Vagally mediated effects of glucagon-like peptide 1: in vitro and in vivo gastric actions
Gregory M. Holmes et al.
JOURNAL OF PHYSIOLOGY-LONDON (2009)
Mice Deficient for Glucagon Gene-Derived Peptides Display Normoglycemia and Hyperplasia of Islet α-Cells But Not of Intestinal L-Cells
Yoshitaka Hayashi et al.
MOLECULAR ENDOCRINOLOGY (2009)
A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
Jonathan W. Day et al.
NATURE CHEMICAL BIOLOGY (2009)
Enhanced Weight Loss With Pramlintide/Metreleptin: An Integrated Neurohormonal Approach to Obesity Pharmacotherapy
Eric Ravussin et al.
OBESITY (2009)
GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism
Yazhou Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Passing the baton in class B GPCRs: peptide hormone activation via helix induction?
Christoph Parthier et al.
TRENDS IN BIOCHEMICAL SCIENCES (2009)
Search for α-helical propensity in the receptor-bound conformation of glucagon-like peptide-1
Eunice N. Murage et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas
J. de Heer et al.
DIABETOLOGIA (2008)
Acute Effects of Glucagon-Like Peptide-1 on Hypothalamic Neuropeptide and AMP Activated Kinase Expression in Fasted Rats
Sanghee Seo et al.
ENDOCRINE JOURNAL (2008)
Amylin-Mediated Restoration of Leptin Responsiveness in Diet-Induced Obesity: Magnitude and Mechanisms
James L. Trevaskis et al.
ENDOCRINOLOGY (2008)
An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose Homeostasis
Laurie L. Baggio et al.
GASTROENTEROLOGY (2008)
Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice
Rachel A. Davey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Regulation of Islet Hormone Release and Gastric Emptying by Endogenous Glucagon-Like Peptide 1 after Glucose Ingestion
Marzieh Salehi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Modulation of taste sensitivity by GLP-1 signaling
Y. -K. Shin et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Glucagon-like peptide I receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease
Alexander Harkavyi et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease
Goran Bertilsson et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies
Jonathan D. Roth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Gastric emptying in response to IAPP and CCK in rats with subdiaphragmatic afferent vagotomy
Johan Wickbom et al.
REGULATORY PEPTIDES (2008)
Combination therapy with amylin and peptide YY[3-36] in obese rodents: Anorexigenic synergy and weight loss additivity
Jonathan D. Roth et al.
ENDOCRINOLOGY (2007)
Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight
Christine Mack et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats
Torsten P. Vahl et al.
ENDOCRINOLOGY (2007)
Small molecule ago-allosteric modulators of the human glucagon-like peptide-1 (hGLP-1) receptor
Min Teng et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
The physiology of glucagon-like peptide 1
Jens Juul Holst
PHYSIOLOGICAL REVIEWS (2007)
Modulation of the satiating effect of amylin by central ghrelin, leptin and insulin
M. Osto et al.
PHYSIOLOGY & BEHAVIOR (2007)
Lesion of the lateral parabrachial nucleus attenuates the anorectic effect of peripheral amylin and CCK
Csilla Becskei et al.
BRAIN RESEARCH (2007)
Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study
Steven R. Smith et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: A phase 2, randomized, placebo-controlled, dose-escalation study
Louis Aronne et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
GLP-1 receptor expression in human tumors and human normal tissues:: Potential for in vivo targeting
Meike Koerner et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Postprandial glucagon-like peptide-1 (GLP-1) response is positively associated with changes in neuronal activity of brain areas implicated in satiety and food intake regulation in humans
Nicola Pannacciulli et al.
NEUROIMAGE (2007)
Glucagon-like peptide-1 excites pancreas-projecting preganglionic vagal motoneurons
S. Wan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Mechanisms of action of glucagon-like peptide 1 in the pancreas
Maire E. Doyle et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Leptin regulation of the anorexic response to glucagon-like peptide-1 receptor stimulation
Diana L. Williams et al.
DIABETES (2006)
Antiobesity effects of the β-cell hormone amylin in diet-induced obese rats:: Effects on food intake, body weight, composition, energy expenditure, and gene expression
Jonathan D. Roth et al.
ENDOCRINOLOGY (2006)
Central nervous system control of food intake and body weight
G. J. Morton et al.
NATURE (2006)
Inhibitory effect of GLP-1 on gastric motility persists after vagal deafferentation in pigs
Carl Frederik Nagell et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2006)
Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively
NM Neary et al.
ENDOCRINOLOGY (2005)
Peripheral exendin-4 and peptide YY3-36 synergistically reduce food intake through different mechanisms in mice
T Talsania et al.
ENDOCRINOLOGY (2005)
GIP and GLP-1 as incretin hormones: Lessons from single and double incretin receptor knockout mice
T Hansotia et al.
REGULATORY PEPTIDES (2005)
Evaluation of interactions between CCK and GLP-1 in their effects on appetite, energy intake, and antropyloroduodenal motility in healthy men
IM Brennan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2005)
The inhibitory effects of peripheral administration of peptide YY3-36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway
CR Abbott et al.
BRAIN RESEARCH (2005)
The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem
E Alvarez et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors
T Hansotia et al.
DIABETES (2004)
Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients
P Hollander et al.
OBESITY RESEARCH (2004)
Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats
A Mollet et al.
PHYSIOLOGY & BEHAVIOR (2004)
Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes
LL Nielsen et al.
REGULATORY PEPTIDES (2004)
Peripheral amylin activates circumventricular organs expressing calcitonin receptor a/b subtypes and receptor-activity modifying proteins in the rat
SW Barth et al.
BRAIN RESEARCH (2004)
A recombinant human glucagon-like peptide (GLP)-1-albumin protein (Albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis
LL Baggio et al.
DIABETES (2004)
Interaction between GLP-1 and CCK-33 in inhibiting food intake and appetite in men
JP Gutzwiller et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2004)
Glucagon-like peptide-1: Regulation of insulin secretion and therapeutic potential
J Gromada et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2004)
The anorectic hormone amylin contributes to feeding-related changes of neuronal activity in key structures of the gut-brain axis
T Riediger et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2004)
Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypcptide (GIP) as future antidiabetic agents
BD Green et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
New insights into the regulation of glucagon secretion by glucagon-like peptide-1
J Gromada et al.
HORMONE AND METABOLIC RESEARCH (2004)
Expression of calcitonin gene-related peptide type 1 receptor mRNA and their activity-modifying proteins in the rat nucleus accumbens
N Li et al.
NEUROSCIENCE LETTERS (2004)
GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine
K Mortensen et al.
REGULATORY PEPTIDES (2003)
International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors
DR Poyner et al.
PHARMACOLOGICAL REVIEWS (2002)
G protein-coupled receptor allosterism and complexing
A Christopoulos et al.
PHARMACOLOGICAL REVIEWS (2002)
Acute 3rd-ventricular amylin infusion potently reduces food intake but does not produce aversive consequences
PA Rushing et al.
PEPTIDES (2002)
Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier
AJ Kastin et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2002)
Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers
MA Nauck et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: A physiological approach toward improved metabolic control
C Weyer et al.
CURRENT PHARMACEUTICAL DESIGN (2001)
Glucagon-like peptide 1 receptor signaling influences topography of islet cells in mice
Z Ling et al.
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY (2001)
Biological activities of glucagon-like peptide-1 analogues in vitro and in vivo
Q Xiao et al.
BIOCHEMISTRY (2001)
Share Paper
